12:00 AM
 | 
Jan 05, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Tacrolimus: Phase III started

LifeCycle began an international Phase III trial of once-daily LCP-Tacro vs. twice-daily Prograf in 300 stable kidney transplant patients. Astellas Pharma Inc. (Tokyo:4503, Tokyo, Japan)...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >